Visual Performance Intraocular Lens (IOL) MicroPure 1.2.3.

Launched by BEAVER-VISITEC INTERNATIONAL, INC. · Sep 28, 2017

Keywords

ClinConnect Summary

The examinations consist of visual acuity data, contrast sensitivity exams, slitlamp examinations and posterior capsule opacification (PCO) grading.

Follow up will be up to 24 months postoperative.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Cataractous eyes with no comorbidity
• • Availability, willingness and sufficient cognitive awareness to comply with examination procedures
• • Signed informed consent
• Exclusion Criteria:
• • Irregular astigmatism
• • Age of patient \< 45 years
• • Regular corneal astigmatism \> 0.75 D on study eye as measured by an automatic keratometer (regularity determined by the topography of the keratometry)
• • Difficulty for cooperation (distance from their home, general health condition)
• • Acute or chronic disease or illness that would increase risk or confound study results (e.g. diabetes mellitus (with retinopathy), immunocompromised, glaucoma etc...)
• • Any ocular comorbidity
• • History of ocular trauma or prior ocular surgery including refractive procedures
• • Capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome, chronic Uveitis, Marfan's syndrome)
• • Pupil abnormalities (non-reactive, tonic pupils, abnormally shaped pupils or pupils that do not dilate under mesopic/scotopic conditions)
• • Complicated surgery